User profiles for E. Yoshida
Eiichi YoshidaTokyo University of Science Verified email at rs.tus.ac.jp Cited by 8926 |
[HTML][HTML] Choledochal cysts: part 1 of 3: classification and pathogenesis
J Singham, EM Yoshida… - Canadian Journal of …, 2009 - ncbi.nlm.nih.gov
Much about the etiology, pathophysiology, natural course and optimal treatment of cystic
disease of the biliary tree remains under debate. Gastroenterologists, surgeons and …
disease of the biliary tree remains under debate. Gastroenterologists, surgeons and …
[HTML][HTML] Interferon-based combination anti-viral therapy for hepatitis C virus after liver transplantation: a review and quantitative analysis
CS Wang, HH Ko, EM Yoshida, CA Marra… - American Journal of …, 2006 - Elsevier
… Yoshida has received unrestricted research grants from Hoffman-LaRoche Canada,
GlaxoSmithKline Canada, Fujisawa Canada, Pfizer Canada, Jansen-Ortho Canada. He has …
GlaxoSmithKline Canada, Fujisawa Canada, Pfizer Canada, Jansen-Ortho Canada. He has …
Acute fatty liver of pregnancy
HH Ko, E Yoshida - Canadian Journal of Gastroenterology and …, 2006 - hindawi.com
Acute fatty liver of pregnancy (AFLP) is a rare, potentially fatal complication that occurs in the
third trimester or early postpartum period. Although the exact pathogenesis is unknown, this …
third trimester or early postpartum period. Although the exact pathogenesis is unknown, this …
[HTML][HTML] Telaprevir for previously untreated chronic hepatitis C virus infection
…, R Sola, RA Terg, EM Yoshida… - … England Journal of …, 2011 - Mass Medical Soc
Background In phase 2 trials, telaprevir, a hepatitis C virus (HCV) genotype 1 protease
inhibitor, in combination with peginterferon–ribavirin, as compared with peginterferon–ribavirin …
inhibitor, in combination with peginterferon–ribavirin, as compared with peginterferon–ribavirin …
[HTML][HTML] Sofosbuvir for hepatitis C genotype 2 or 3 in patients without treatment options
…, SC Gordon, KV Kowdley, EM Yoshida… - New England journal …, 2013 - Mass Medical Soc
Background Patients chronically infected with hepatitis C virus (HCV) genotype 2 or 3 for
whom treatment with peginterferon is not an option, or who have not had a response to prior …
whom treatment with peginterferon is not an option, or who have not had a response to prior …
[HTML][HTML] Sofosbuvir and velpatasvir for HCV genotype 1, 2, 4, 5, and 6 infection
…, F Mazzotta, C Moreno, E Yoshida… - … England Journal of …, 2015 - Mass Medical Soc
Background A simple treatment regimen that is effective in a broad range of patients who
are chronically infected with the hepatitis C virus (HCV) remains an unmet medical need. …
are chronically infected with the hepatitis C virus (HCV) remains an unmet medical need. …
[HTML][HTML] ABT-450/r–ombitasvir and dasabuvir with ribavirin for hepatitis C with cirrhosis
…, H Wedemeyer, T Berg, EM Yoshida… - … England Journal of …, 2014 - Mass Medical Soc
Background Interferon-containing regimens for the treatment of hepatitis C virus (HCV)
infection are associated with increased toxic effects in patients who also have cirrhosis. We …
infection are associated with increased toxic effects in patients who also have cirrhosis. We …
M-TRAN: Self-reconfigurable modular robotic system
In this paper, a novel robotic system called modular transformer (M-TRAN) is proposed. M-TRAN
is a distributed, self-reconfigurable system composed of homogeneous robotic modules…
is a distributed, self-reconfigurable system composed of homogeneous robotic modules…
Retention of multilineage differentiation potential of mesenchymal cells during proliferation in response to FGF
…, K Miyazaki, H Pan, C Koike, E Yoshida… - Biochemical and …, 2001 - Elsevier
Mesenchymal stem cells (MSC) that can differentiate to various connective tissue cells may
be useful for autologous cell transplantation to defects of bone, cartilage, and tendon, if MSC …
be useful for autologous cell transplantation to defects of bone, cartilage, and tendon, if MSC …
Two domains of Nrf2 cooperatively bind CBP, a CREB binding protein, and synergistically activate transcription
Y Katoh, K Itoh, E Yoshida, M Miyagishi… - Genes to …, 2001 - Wiley Online Library
… Neh4 and Neh5 both individually and cooperatively bind to CBP (CREB (cAMP Responsive
Element Binding protein) Binding Protein). In fact, the specific inhibitor of CBP, adenovirus …
Element Binding protein) Binding Protein). In fact, the specific inhibitor of CBP, adenovirus …